important function in various cancers. 2, [7] [8] [9] Solid tumours have access to circulating lipoproteins, 7, 10 and uptake and utilization of CEs are linked to cell proliferation, invasion and endoplasmic reticulum homoeostasis. 7, 8, [11] [12] [13] However, several studies have reported that high-grade ccRCC is associated with decreased lipid content. 14, 15 The mechanisms responsible for grade-dependent decreases in cellular lipids remain unknown, which is indicative of the complexity of aberrant lipid metabolism in ccRCC. Restructuring of lipid metabolism constitutes a recurrent pattern in ccRCC and correlates with tumour grade and prognosis. 16 Lysosomal acid lipase (LAL) is a key regulator of CE metabolism.
In lysosomes, LAL hydrolyses CEs and triglycerides (TGs) to produce free fatty acids (FFAs) and cholesterol. 17 As the only hydrolase that cleaves CEs in lysosomes, LAL is critical for degradation of CEs taken up by lipoprotein/scavenger receptors such as low density lipoprotein receptor (LDLR), lipoprotein receptor-related protein 1 (LRP1), very low density lipoprotein receptor (VLDLR) and CD36. [18] [19] [20] LAL also plays a vital role in recycling intrinsic lipids via autophagy (ie, lipophagy). 21 The byproducts, free cholesterol (FC) and FFAs, can be utilized by cells, and any excess FC or FFAs are re-esterified and transported back to lipid droplets to serve as a reservoir. Thus, both uptake and recycling of CEs are regulated by LAL. LAL has been shown to affect the turnover of various bioactive lipids, such as retinoid, 22 dehydroepiandrosterone 23 and oleoylethanolamide. 24 Furthermore, LAL regulates metabolism of long-chain fatty acids. [24] [25] [26] It is known that compared to cholesterol oleate or saturated CEs, polyunsaturated CEs containing arachidonate are preferentially hydrolysed by LAL. 27 In addition, overexpression of LAL in
Caenorhabditis elegans increases the level of arachidonic acid (AA). 24 Conversely, LAL deficiency leads to sequestration of arachidonate in CEs and TGs in the liver and spleen of rats. 28 Nonetheless, the role of LAL in cancer cells has yet to be clarified. Transcriptional analysis of data from The Cancer Genome Atlas (TCGA) revealed that LAL is up-regulated in ccRCC. Meanwhile, accumulating evidence has shown that lipoprotein receptor-lysosome pathways participate in cancer development and progression. [7] [8] [9] 13 LAL may either facilitate lipid uptake by digesting lipoprotein contents or mobilize intracellular CEs. Accordingly, we sought to determine whether LAL could play an important role in orchestrating CE metabolism to promote ccRCC progression. Here, we demonstrate LAL promoted cell proliferation and survival via metabolism of eicosanoid 14,15-epoxyeicosatrienoic acids (EET) and activation of the Src/Akt pathway in ccRCC.
| MATERIAL S AND ME THODS

| Samples
Tissue samples from 30 patients with ccRCC were obtained from
Shanghai General Hospital, Shanghai Jiao Tong University School of
Medicine. This investigation was conducted in accordance with ethical standards and was approved by the authors' institutional review board. This study conformed to Declaration of Helsinki. Informed consent was obtained from each patient.
| Cell culture
The human ccRCC cell lines 786-O, 769-P, Caki-1, OSRC-2 and human kidney tubule epithelial HK-2 cells were obtained from
Type Culture Collection of the Chinese Academy of Sciences. All cell lines were authenticated and characterized by the supplier.
The cells were expanded immediately and cryopreserved. Cells were used within 6 months of resuscitation. All cells were cultured in RPMI 1640 (Invitrogen Life Technologies, Carlsbad, California, USA) supplemented with 10% FBS, 2 mmol/L L-glutamine, 100 units/mL penicillin and 100 g/mL streptomycin at 37° C in a humidified 5% CO 2 atmosphere.
| Immunohistochemistry (IHC)
Heat-induced antigen retrieval was applied using Tris/EDTA buffer (pH 9.0). Next, sections were treated with 3% hydrogen peroxide in methanol to block endogenous peroxidase activ- Negative control assays were performed using normal IgG. All images were photographed using the Nikon Eclipse Ti microscope.
| Tissue Microarrays
Paraffin-embedded ccRCC tissue microarrays were obtained from US Biomax. The tissue microarray and IHC analyses were performed as previously described. 29, 30 The intensity of immunostaining was evaluated by two independent pathologists without knowledge of the clinicopathological data. A semi-quantitative H-score ranging from 0 to 300 was calculated by multiplying the staining intensity according to the manufacturer's instructions. The forward and reverse primers set for human LAL were 5′-accagagttatcctcccacatac-3′
and 5′-agtcaagatgctcccattcc-3′ respectively. The forward and reverse primers set for human 18s RNA (internal controls) were 5′-gtaacccgttgaaccccatt-3′ and 5′-ccatccaatcggtagtagcg-3′ respectively.
| siRNA transfection
Custom-designed siRNAs directed against LAL (siLAL1 GGCCAAAUUAGGACGAUUATT, siLAL2 GGCAACAGCAGAGGA AAUATT), were synthesized and annealed (GenePharma, Shanghai, China). Cells were transfected with target and control siRNAs using
Lipofectamine RNAiMAX (Invitrogen Life Technologies, Carlsbad, California, USA) according to the manufacturer's instructions.
| shRNA and cDNA transfection
The LAL (TRCN0000029245, TRCN0000029247) shRNA construct was obtained from TRC lentiviral shRNA Libraries (Broad Institute, Cambridge, Maryland, USA). The cDNA encoding human LAL was obtained by reverse transcription PCR and verified by sequencing.
The LAL cDNA was then subcloned into the lentiviral vector pLVX-IRES-ZsGreen1 (Clontech, Mountain View, California, USA). Stably transfected cell lines expressing the cDNA and shRNA were generated as previously described. 
| Western blot analysis
Cells were lysed using Radio Immunoprecipitation Assay (RIPA)
buffer supplemented with protease and phosphatase inhibitors and protein concentration was measured using a BCA Protein Assay kit (Pierce, Waltham, Massachusetts, USA).Western blot analyses were as previously described. 29 The membranes were then incubated with following primary antibodies: anti-tubulin and anti-actin (Sigma, 
| Cell proliferation
Cells were reversely transfected with siRNAs and plated in 6-well plates at a density of 4000 cells/well; this was considered day 1.
Cell numbers were counted on days 2, 3 and 4. Alternatively, stably transfected cells were plated in 6-well plates at a density of 4000 cells/well, which was considered day 1. Cell numbers were then counted using the trypan blue exclusion method on days 2,
and 4.
For the bromodeoxyuridine (Brdu) analysis, cells were pulsed with 
| Plate colony formation assay
Two thousand cells were seeded and cultured for 2 weeks under indicated condition, then fixed for 30 minutes in 10% formaldehyde.
Cell colonies were stained for 30 minutes with crystal violet (SigmaAldrich, St. Louis, Missouri, USA), washed and quantified.
| Cell death assay
Cells were seeded on 6-well culture plates. Each treatment group was seeded in triplicate. After overnight attachment, cells were treated with 8 nM paclitaxel. Following incubation, both attached and unattached cells were harvested. The percentage of cell death was measured using the trypan blue exclusion assay as previously described. 31 For flow cytometry analysis, cells were labelled using
Annexin V-FITC/PI kit (Yeasen, Shanghai, China) and analysed by flow cytometry according to the manufacturer's instructions.
| Metabolic assay
To measure intracellular arachidonic acid, OSRC-2 cells with shCtrl, shLAL1 and shLAL2 were washed with PBS and trypsinized.
Arachidonic acid was extracted and analysed using ultra performance lipid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) by Metabo-profile Biotechnology Co., Ltd, Shanghai,
China. The concentrations of arachidonic acid in samples were obtained by comparing to a set of standard samples of known concentration of arachidonic acid (ie, calibration curve). The data were normalized to cell counts.
To measure 14,15-EET/DHET, 80% confluent cells in 10 cm dishes were trypsinized and re-suspended in 2 mL of PBS with triphenylphosphine. 14,15 EET/DHET was extracted and measured using a 14,15-EET/DHET ELISA kit (Detroit R&D, Detroit, Michigan, USA)
according to the manufacturer's instructions.
To measure total cholesterol and free cholesterol, 80% confluent cells in 6 cm dishes were trypsinized and re-suspended in a chloroform/isopropanol/Nonidet P-40 mix with a ratio of 7:11:0.1 respectively. Total cholesterol and free cholesterol were extracted and assessed using a cholesterol quantitation kit (Sigma, St. Louis, Missouri, USA).
| RNAseq data analysis
Raw files of the GSE46340 data set were downloaded from GEO 32 websites. The Illumina universal adapter was trimmed using trim_ga-lore. Reads were aligned to the mouse GRCm38 reference genome using HISAT (2.0.1) 33 and counted using featureCounts (1.5.0). 34 We performed all subsequent analyses using limma 35 and r version 3.2.3
(http://www.r-project.org/).
| Network analysis
We used a slightly modified network analysis method described by Akbani 36 and Yasin et al. 37 The models were estimated using ARACNE-A 38 and Meinshausen-Buhlmann graph estimation.
39
Stability Approach to Regularization Selection (StARS) was applied for high-dimensional inference of undirected graphs. 40 
| Quantification and correlation of IHC staining
Correlation of p-Akt and LAL staining were analysed using QuPath 
| Animal experiments
All animal experiments were conducted using protocols approved 
| Statistical analysis
Statistical analysis was performed using r version 3.2.3 (http:// www.r-project.org/). Experiments were performed at least three times independently. P values were 2-sided and P < 0.05 was considered statistically significant.
| RE SULTS
| LAL is up-regulated in human ccRCC and predicts survival
To initially gain insight into the expression pattern of LAL, we analysed public RNA-sequencing data from TCGA and found that LAL was up-regulated in ccRCC. Among all cancer types in TCGA programme, the ccRCC (kidney renal clear cell carcinoma, KIRC) cohort 42 had the highest mRNA level of LAL ( Figure 1A ) indicating that LAL may play an important role in ccRCC. To validate the up-regulation of LAL at the transcriptional level in ccRCC, we compared LAL mRNA levels in patient-matched ccRCC/normal tissues (n = 19 pairs) using
qRT-PCR and found that LAL was significantly up-regulated in the former tissue ( Figure 1B ). We also compared LAL protein levels in patient-matched ccRCC/normal tissues (n = 10 pairs) using western blotting ( Figure 1C ). The protein level of LAL was higher in ccRCC samples compared with matched normal kidney tissue from the same patients ( Figure 1C ). The level of LAL in cancer and normal kidney tissues were quantified, and their ratios were represented as tumour to normal (T/N) ratios. Interestingly, when we compared the T/N ratios using the Fuhrman grading system, we found significantly higher T/N ratios for cancer with a higher grade (grades 3 and 4) compared with lower grades (grades 1 and 2) ( Figure 1D ). Furthermore, IHC
showed LAL to be abundantly expressed in ccRCC tissues, whereas We found LAL expression increased gradually and significantly in normal, grade 1-3 ccRCC tissues ( Figure 1F ).
Because the level of LAL expression was correlated with tumour grade, we inferred that up-regulation of LAL may promote ccRCC progression and predict poor prognosis. LAL expression groups were obtained using the median H score as the cut-off point. Log-rank test
and Kaplan-Meier plot demonstrated significantly shorter overall survival time for patients with high tumour expression of LAL compared to the low-expression group (P < .05, Figure 1G ).
| LAL is required for cell proliferation in kidney cancer cell lines
The To investigate the long-term effect of LAL, we established Caki-1 and OSRC-2 cells stably infected with a non-target control shRNA (shCtrl) or two independent shRNAs targeting LAL (shLAL1 and shLAL2).
The results showed a significant decline in LAL protein levels with shLAL1 and shLAL2 compared to control cells ( Figure 2B , Figure S1E ).
The Caki-1 and OSRC-2 cell proliferation rate were significantly attenuated following knockdown of LAL expression ( Figure 2C , Figure S1F ). The BrdU incorporation assay showed that reduced S and G2/Mphase percentage was observed in Caki-1 cells with shLAL1 or shLAL2, accompanied by G1 phase arrest ( Figure 2D) . Similarly, the clonogenicity was also significantly attenuated following knockdown of LAL expression ( Figure 2E ). However, Annexin V staining suggested that LAL suppression did not lead to a significant increase in apoptosis (data not shown).
To determine the effects of stable LAL overexpression on the proliferative activities of ccRCC cells, we established Caki-1 and OSRC-2 Figure   S1G ) and counted cells on days 1, 2, 3 and 4 after plating in equal numbers. Proliferation was mildly increased in both cell lines stably expressing LAL cDNA compared to control cells ( Figure 2G , Figure S1H ). The
BrdU incorporation assay showed that increased S-phase percentage was observed in Caki-1 cells with stably expressing LAL ( Figure 2H ).
| LAL is required for cholesterol ester metabolism in ccRCC
Since ccRCC up-regulates expression of several lipoprotein receptors 18, 20, 43 and exhibits aberrant lipid metabolism, we investigated whether LAL plays an important role for CE metabolism in ccRCC.
Thus, we detected cellular free cholesterol and CEs in OSRC-2 cells with shCtrl, shLAL1, shLAL2, control vector and an LAL expression plasmid. Similar to previous studies, knockdown of LAL resulted in an increase in CEs ( Figure 3A) . Free cholesterol was mildly decreased in shLAL-transfected cells compared with control cells ( Figure 3B ).
Overexpression of LAL led to opposite results (Figure 3A-C), which
is consistent with our finding of a grade-dependent increase in LAL and decrease in CEs. However, knockdown of LAL did not significantly alter the level of total free fatty acids ( Figure 3C ).
Furthermore, we quantified CEs and FC in human ccRCC tissues of different Fuhrman grades (n = 30). Levels of CEs were significantly decreased in higher-grade ccRCC tissue (grades 3 and 4) compared
with lower-grade tissue (grades 1 and 2) ( Figure 3D ). Levels of FC were comparable or even slightly increased in higher-grade ccRCC.
These alterations of CE and FC levels are consistent with the expression pattern of LAL. Taken together, these data show that LAL is required for CE metabolism in ccRCC.
| Suppression of LAL attenuates ccRCC growth and survival by regulating Akt phosphorylation
Although it has been reported that FoxO1 positively regulates LAL expression in adipocytes, 44 FoxO1 is negatively regulated by Akt and down-regulated in the majority of human renal tumour samples.
45,46
Thus, we applied IHC to compare LAL, FoxO1 and phosphorylated Akt (p-Akt) (Ser473) and total Akt protein levels in adjacent slices of kidney and ccRCC samples. Interestingly, the level of p-Akt exhibited a negative correlation with FoxO1 ( Figure 4A ) and a strong Akt is a key regulator of both cell growth and survival, and previous research has shown that hyperactivated Akt can lead to pro-survival signals in ccRCC. 47 We therefore evaluated whether 
| LAL induces activation of Src
To further elucidate the mechanism of decreased Akt phos- To determine whether Src is upstream of both LAL and Akt, we compared transcriptional profiles of mouse embryonic fibroblasts stably transfected with a retroviral vector/constitutively active mutant Src (Y527F) and the livers of wild-type/Src transgenic mice using public datasets GSE46340 and GSE15815. In both data sets, activated Src did not alter the mRNA level of LAL ( Figure S3A, B) .
Therefore, we speculated that LAL-mediated Akt activation is dependent on Src.
To test whether Src contributes to LAL-mediated Akt activation, we compared the level of p-Src (Y416) in OSRC-2 cells harbouring shCtrl, shLAL1 and shLAL2. Suppression of LAL decreased the level of p-Src in these cells ( Figure 6C) . Interestingly, the basal levels of p-ERK and p-STAT3 were unchanged after suppression of LAL. In contrast, overexpression of LAL led to higher levels of p-Src and pAkt ( Figure 6D ).
| LAL promotes phosphorylation of Src by regulating metabolism of epoxyeicosatrienoic acids
Although LAL did not alter total free fatty acid levels, we noticed that LAL changed the intracellular concentration of long-chain fatty acids such as arachidonic acid (AA). 24, 28, 51 Given defects in the intracellular transformation of linoleic acid to AA in ccRCC, 52 we speculate Figure 7A ). In addition, the concentration with the peak stimulating effect was much lower than that (50 μM) commonly reported in the literature. Unbiased metabolomics revealed that AA is increased in high-grade ccRCC, 19 which is consistent with our finding of a grade-dependent increase in LAL. Then, we confirmed that LAL regulates the level of AA (Table 1 ) using mass spectrometry. These data collectively imply that c-Src/Akt activation may be linked to a pathway that is dependent on AA metabolism.
Furthermore, we evaluated expression of all enzymes that metabolize AA using a public microarray dataset of normal kidney and ccRCC (GSE40435) 53 ( Figure S4A ) and found that the cytochrome P450 CYP2J2 was drastically up-regulated in ccRCC tissue. This was also confirmed using qRT-PCR ( Figure 7B ). We then notice that 14,15-EET, the most abundant EET regioisomer generated by CYP2J2, acts as a potent mitogen in renal epithelial cells, leading to activation of Akt in a Src-dependent manner. [54] [55] [56] [57] In addition, 14,15-diHETrE, a downstream metabolite of 14,15-EET, was significantly elevated in high-grade ccRCC compared with low-grade carcinoma.
19
To explore the possible role of LAL in 14,15-EET production, the cellular 14,15-EET content was measured in shCtrl and shLAL Caki-1 cells, with a significantly lower level found in the latter ( Figure 7C ). Figure S4D , E).
| LAL suppression inhibits tumour growth in vivo
To 
| D ISCUSS I ON
Rather than increasing de novo synthesis of fatty acids and cholesterol, ccRCC up-regulates expression of several lipoprotein receptors such as LRP1, VLDLR and CD36 in order to absorb extracellular lipids. [18] [19] [20] However, the importance of extracellular lipid utilization remains relatively poorly defined. In the present study, we first es- In the present study, we found that LAL decreased the level of CEs and increased the level of FC (Figure 3) , which is consistent with trends of CEs and FC in different grades of ccRCC tissues.
Interestingly, fold-changes of FC and FFA are significantly smaller than those of CEs. In fact, unlike CEs, intracellular levels of FC and
FFAs are tightly regulated. Excessive FC will be re-esterified or exported through reverse cholesterol transport, while depletion of FC will activate its de novo synthesis process. Similarly, excessive FFAs will be consumed during the formation process of CEs and triacylglyceride, while depletion of non-essential FFAs will also activate their de novo synthesis processes. The composition of FFAs is often changed following LAL alteration. 24 It has been reported that LAL preferentially hydrolyses polyunsaturated cholesterol esters. 27 Depletion of LAL could stimulate de novo synthesis of non-essential fatty acids (data not shown). These may be the reasons through which LAL alters the level of AA rather than total FFAs. It is interesting to observe that LAL depletion reduces the 14,15-EET production in lipoprotein deficient (LPDS) medium ( Figure 7 ). It is known that LAL recycles intrinsic lipids. One possible mechanism is that LAL can mobilize intrinsic lipids and release AA which can be converted into 14,15-EET.
Interestingly, we observed that LAL exhibited a strong positive correlation with p-Akt (Figure 4 ). In general, lysosome-related genes are negatively regulated by the Akt/mTOR pathway.
63-65
Why lysosomal gene LAL been co-expressed with Akt remains an open question. Although constitutive activation of the PI3K/Akt/ mTOR pathway in high-grade cancer usually suppresses autophagylysosome processes, LAL does not appear to exhibit this tendency in ccRCC. One interesting point is that LAL is highly homologous to human gastric lipase, which plays an important role in the digestion of dietary TGs in the gastrointestinal tract. 66 We presume that metabolic signals from LAL maybe evolutionarily interpreted as a plentiful nutrient supply, activating nutrient sensors and promoting cell growth.
We have found that LAL regulates the level of epoxyeicosatrienoic acids and the activity of Src and Akt in ccRCC cells
( Figure 7C, D) . It has been reported that epoxyeicosatrienoic acids exert their mitogenic effects predominantly through a Src kinase-mediated pathway. 55 However, certain previous studies have shown that EETs are capable of activating epidermal growth factor receptor (EGFR) in endothelial cells and cancer cells. 54, 67 In addition, it has been reported that Src phosphorylates and activates EGFR 68 and that EGFR stimulation leads to activation of Src. 69 Nonetheless, additional work is required to address whether 14,15-EET-derived Src-Akt signalling required the involvement of EGFR in ccRCC.
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